Loading…
Recent trends of natural based therapeutics for mitochondria targeting in Alzheimer’s disease
•Alzheimer’s disease (AD) is the most ubiquitous neurodegenerative disorder.•Targeting multi-pathway via natural products may prevent mitochondria dysfunctionality.•We have focused on the pathophysiology events of mitochondrial dysfunction in AD. Alzheimer’s disease (AD) is the most ubiquitous neuro...
Saved in:
Published in: | Mitochondrion 2022-05, Vol.64, p.112-124 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | •Alzheimer’s disease (AD) is the most ubiquitous neurodegenerative disorder.•Targeting multi-pathway via natural products may prevent mitochondria dysfunctionality.•We have focused on the pathophysiology events of mitochondrial dysfunction in AD.
Alzheimer’s disease (AD) is the most ubiquitous neurodegenerative disorder with impaired cognitive functionality. Till date, the specific pathophysiology related to AD is still elusive. Recent reports suggest mitochondrial dysfunctionality like oxidative stress, Ca2+ disbalance, apoptosis, decrease energy and its metabolism plays an important. Recent reports about mitochondrial mechanisms and dynamics in AD unravelled new insights of molecular targets. Targeting multi-pathway via natural products may attenuate and prevent the mitochondria dysfunctionality. In this review, we have focused on the pathophysiology events of mitochondrial dysfunction in AD as well as mitochondrial fusion and fission mechanisms, role of aging in multicellular organisms, and how these connect to cell cycle regulation, and transmission of energy status. |
---|---|
ISSN: | 1567-7249 1872-8278 |
DOI: | 10.1016/j.mito.2022.03.006 |